vs
Healthpeak Properties（DOC）与海斯特耶鲁（HY）财务数据对比。点击上方公司名可切换其他公司
海斯特耶鲁的季度营收约是Healthpeak Properties的1.3倍（$923.2M vs $702.9M），Healthpeak Properties净利率更高（51.6% vs -5.7%，领先57.3%），Healthpeak Properties同比增速更快（-6.6% vs -13.5%），过去两年Healthpeak Properties的营收复合增速更高（0.5% vs -6.5%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
海斯特-耶鲁物料搬运公司通过其全资运营子公司海斯特-耶鲁集团，主要以海斯特与耶鲁品牌在全球范围设计研发、生产销售全系列叉车，并提供售后配件与相关服务。该公司2002年起就在NACCO工业集团内独立运营，最终于2012年从NACCO分拆独立。
DOC vs HY — 直观对比
营收规模更大
HY
是对方的1.3倍
$702.9M
营收增速更快
DOC
高出6.9%
-13.5%
净利率更高
DOC
高出57.3%
-5.7%
两年增速更快
DOC
近两年复合增速
-6.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $923.2M |
| 净利润 | $363.0M | $-52.5M |
| 毛利率 | — | 14.2% |
| 营业利润率 | 0.7% | -4.0% |
| 净利率 | 51.6% | -5.7% |
| 营收同比 | -6.6% | -13.5% |
| 净利润同比 | 28.3% | -609.7% |
| 每股收益（稀释后） | $0.28 | $-2.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCHY
| Q1 26 | $702.9M | — | ||
| Q4 25 | $719.4M | $923.2M | ||
| Q3 25 | $705.9M | $979.1M | ||
| Q2 25 | $694.3M | $956.6M | ||
| Q1 25 | $702.9M | $910.4M | ||
| Q4 24 | $698.0M | $1.1B | ||
| Q3 24 | $700.4M | $1.0B | ||
| Q2 24 | $695.5M | $1.2B |
净利润DOCHY
| Q1 26 | $363.0M | — | ||
| Q4 25 | $114.0M | $-52.5M | ||
| Q3 25 | $-117.1M | $-2.3M | ||
| Q2 25 | $31.7M | $-13.9M | ||
| Q1 25 | $42.8M | $8.6M | ||
| Q4 24 | $4.5M | $10.3M | ||
| Q3 24 | $85.9M | $17.2M | ||
| Q2 24 | $146.0M | $63.3M |
毛利率DOCHY
| Q1 26 | — | — | ||
| Q4 25 | — | 14.2% | ||
| Q3 25 | 58.6% | 15.9% | ||
| Q2 25 | 60.2% | 17.6% | ||
| Q1 25 | 61.1% | 19.5% | ||
| Q4 24 | 60.3% | 19.4% | ||
| Q3 24 | 60.0% | 19.0% | ||
| Q2 24 | 60.6% | 22.2% |
营业利润率DOCHY
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | -4.0% | ||
| Q3 25 | 9.2% | 0.2% | ||
| Q2 25 | 5.7% | -0.9% | ||
| Q1 25 | 7.7% | 2.3% | ||
| Q4 24 | -2.2% | 3.0% | ||
| Q3 24 | 14.1% | 3.3% | ||
| Q2 24 | 22.3% | 8.2% |
净利率DOCHY
| Q1 26 | 51.6% | — | ||
| Q4 25 | 73.2% | -5.7% | ||
| Q3 25 | -16.6% | -0.2% | ||
| Q2 25 | 4.6% | -1.5% | ||
| Q1 25 | 6.1% | 0.9% | ||
| Q4 24 | 0.7% | 1.0% | ||
| Q3 24 | 12.3% | 1.7% | ||
| Q2 24 | 21.0% | 5.4% |
每股收益（稀释后）DOCHY
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $-2.97 | ||
| Q3 25 | $-0.17 | $-0.13 | ||
| Q2 25 | $0.05 | $-0.79 | ||
| Q1 25 | $0.06 | $0.48 | ||
| Q4 24 | $0.02 | $0.57 | ||
| Q3 24 | $0.12 | $0.97 | ||
| Q2 24 | $0.21 | $3.58 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | — |
| 总债务越低越好 | — | $251.9M |
| 股东权益账面价值 | $7.8B | $472.0M |
| 总资产 | $21.6B | $2.0B |
| 负债/权益比越低杠杆越低 | — | 0.53× |
8季度趋势，按日历期对齐
现金及短期投资DOCHY
| Q1 26 | $-1.2B | — | ||
| Q4 25 | $467.5M | — | ||
| Q3 25 | $91.0M | — | ||
| Q2 25 | $89.4M | — | ||
| Q1 25 | $70.6M | — | ||
| Q4 24 | $119.8M | — | ||
| Q3 24 | $180.4M | — | ||
| Q2 24 | $106.9M | — |
总债务DOCHY
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | $251.9M | ||
| Q3 25 | $9.1B | $252.2M | ||
| Q2 25 | $9.0B | $245.2M | ||
| Q1 25 | $8.9B | $242.6M | ||
| Q4 24 | $8.7B | $241.9M | ||
| Q3 24 | $8.6B | $247.4M | ||
| Q2 24 | $8.6B | $248.5M |
股东权益DOCHY
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | $472.0M | ||
| Q3 25 | $7.6B | $536.0M | ||
| Q2 25 | $7.9B | $544.7M | ||
| Q1 25 | $8.2B | $510.0M | ||
| Q4 24 | $8.4B | $475.1M | ||
| Q3 24 | $8.6B | $529.9M | ||
| Q2 24 | $8.8B | $465.7M |
总资产DOCHY
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | $2.0B | ||
| Q3 25 | $19.6B | $2.1B | ||
| Q2 25 | $19.8B | $2.1B | ||
| Q1 25 | $19.8B | $2.1B | ||
| Q4 24 | $19.9B | $2.0B | ||
| Q3 24 | $20.0B | $2.2B | ||
| Q2 24 | $20.2B | $2.1B |
负债/权益比DOCHY
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | 0.53× | ||
| Q3 25 | 1.20× | 0.47× | ||
| Q2 25 | 1.14× | 0.45× | ||
| Q1 25 | 1.08× | 0.48× | ||
| Q4 24 | 1.04× | 0.51× | ||
| Q3 24 | 1.00× | 0.47× | ||
| Q2 24 | 0.98× | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $56.5M |
| 自由现金流经营现金流 - 资本支出 | — | $32.9M |
| 自由现金流率自由现金流/营收 | — | 3.6% |
| 资本支出强度资本支出/营收 | 3.4% | 2.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $23.6M |
8季度趋势，按日历期对齐
经营现金流DOCHY
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $56.5M | ||
| Q3 25 | $315.0M | $37.1M | ||
| Q2 25 | $363.5M | $28.9M | ||
| Q1 25 | $279.4M | $-36.4M | ||
| Q4 24 | $1.1B | $80.7M | ||
| Q3 24 | $318.2M | $70.1M | ||
| Q2 24 | $316.2M | $-2.5M |
自由现金流DOCHY
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $32.9M | ||
| Q3 25 | — | $22.6M | ||
| Q2 25 | — | $15.1M | ||
| Q1 25 | — | $-47.0M | ||
| Q4 24 | $333.7M | $62.8M | ||
| Q3 24 | — | $59.9M | ||
| Q2 24 | — | $-14.7M |
自由现金流率DOCHY
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | 3.6% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | -5.2% | ||
| Q4 24 | 47.8% | 5.9% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | -1.3% |
资本支出强度DOCHY
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | 2.6% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | 105.6% | 1.7% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 1.0% |
现金转化率DOCHY
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | -4.23× | ||
| Q4 24 | 235.43× | 7.83× | ||
| Q3 24 | 3.71× | 4.08× | ||
| Q2 24 | 2.17× | -0.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
HY
| Sales Channel Through Intermediary | $281.7M | 31% |
| Aftermarketsales | $179.1M | 19% |
| Sales Channel Directly To Consumer | $173.6M | 19% |
| EMEAHY | $153.3M | 17% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $89.0M | 10% |
| Otherrevenue | $42.4M | 5% |
